Project Name：Aspirin, clopidogrel bisulfate tablets
Registration Classification：3.2
Formulations and specifications ：Tablets: 75mg/100mg, 100mg/100mg
Indications：Used for the prevention of atherosclerosis with clopidogrel and aspirin in the treatment of atherosclerosis and for the continuation of the following symptoms : non- ST segment elevation acute coronary syndrome ( unstable angina or non- Q -wave myocardial infarction ) including undergoing coronary stent after surgery ; thrombolytic therapy with drug treatment of ST segment elevation acute myocardial infarction
Original Research Company：Sanofi
Progress：Has been reported to the State Council , the admissibility number : CXHL1400249; CXHL1400306
Category：Antiplatelet drugs